MIF and B-cell chronic lymphocytic leukemia: MIF loss in TCL1-tg/Mif−/− mice delays CLL development and reduces leukemic cells survival.85 In addition, MIF can also act as a chemokine, recruiting M2 macrophages in leukemic organs, which, differently to cytotoxic type M1, promote tumor progression and suppress the immune response.